NRx Pharmaceuticals' Acquisition Likely to Result in Multiple Avenues of Growth -- Market Talk

Dow Jones01-07

1857 ET [Dow Jones]--NRx Pharmaceuticals plans to acquire Dura Medical and invest $27 million to establish a network of interventional psychiatry clinics, offering services such as ketamine-infusion treatments. This plan positions NRx for growth through expanded services for civilian and veteran communities, D. Boral Capital analysts say in a research note. They add that the plan is also expected to deliver immediate financial benefits, with the acquisition anticipated to be accretive to revenue and earnings before interest, taxes, depreciation and amortization. "The integration of Dura into the HOPE network underscores NRx's commitment to addressing critical mental health needs, particularly among veterans and underserved populations," analysts write. Shares edge higher in postmarket trading after ending the regular session up 30%, to $3.51. (connor.hart@wsj.com)

(END) Dow Jones Newswires

January 06, 2025 19:00 ET (00:00 GMT)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2501292804?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-01-07 08:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2501292804","market":"hk","top_or_hot":-1,"title":"NRx Pharmaceuticals' Acquisition Likely to Result in Multiple Avenues of Growth -- Market Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  1857 ET [Dow Jones]--NRx Pharmaceuticals plans to acquire Dura Medical and invest $27 million to establish a network of interventional psychiatry clinics, offering services such as ketamine-infusion treatments. This plan positions NRx for growth through expanded services for civilian and veteran communities, D. Boral Capital analysts say in a research note. They add that the plan is also expected to deliver immediate financial benefits, with the acquisition anticipated to be accretive to revenue and earnings before interest, taxes, depreciation and amortization. \"The integration of Dura into the HOPE network underscores NRx's commitment to addressing critical mental health needs, particularly among veterans and underserved populations,\" analysts write. Shares edge higher in postmarket trading after ending the regular session up 30%, to $3.51. (connor.hart@wsj.com) \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  January 06, 2025 19:00 ET (00:00 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>NRx Pharmaceuticals' Acquisition Likely to Result in Multiple Avenues of Growth -- Market Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNRx Pharmaceuticals' Acquisition Likely to Result in Multiple Avenues of Growth -- Market Talk\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-01-07 08:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://dowjonesnews.com/newdjn/logon.aspx?AL=N><strong>Dow Jones</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>1857 ET [Dow Jones]--NRx Pharmaceuticals plans to acquire Dura Medical and invest $27 million to establish a network of interventional psychiatry clinics, offering services such as ketamine-infusion ...</p>\n\n<a href=\"https://dowjonesnews.com/newdjn/logon.aspx?AL=N\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"NRXP","symbol_name":"NRX Pharmaceuticals Inc.","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2501292804","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2501292804","pubTimestamp":1736208000,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"1857 ET [Dow Jones]--NRx Pharmaceuticals plans to acquire Dura Medical and invest $27 million to establish a network of interventional psychiatry clinics, offering services such as ketamine-infusion treatments. This plan positions NRx for growth through expanded services for civilian and veteran communities, D. Boral Capital analysts say in a research note. They add that the plan is also expected to deliver immediate financial benefits, with the acquisition anticipated to be accretive to revenue and earnings before interest, taxes, depreciation and amortization. \"The integration of Dura into the HOPE network underscores NRx's commitment to addressing critical mental health needs, particularly among veterans and underserved populations,\" analysts write. Shares edge higher in postmarket trading after ending the regular session up 30%, to $3.51. ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"NRXP":"NRX Pharmaceuticals Inc.","BK4007":"制药"},"translate_title":"NRx Pharmaceuticals的收购可能会带来多种增长途径——市场讨论","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NRXP":0.9},"content_text":"1857 ET [Dow Jones]--NRx Pharmaceuticals plans to acquire Dura Medical and invest $27 million to establish a network of interventional psychiatry clinics, offering services such as ketamine-infusion treatments. This plan positions NRx for growth through expanded services for civilian and veteran communities, D. Boral Capital analysts say in a research note. They add that the plan is also expected to deliver immediate financial benefits, with the acquisition anticipated to be accretive to revenue and earnings before interest, taxes, depreciation and amortization. \"The integration of Dura into the HOPE network underscores NRx's commitment to addressing critical mental health needs, particularly among veterans and underserved populations,\" analysts write. Shares edge higher in postmarket trading after ending the regular session up 30%, to $3.51. (connor.hart@wsj.com) \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 06, 2025 19:00 ET (00:00 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation,merge","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.30.2","shortVersion":"4.30.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2501292804"}